Feedback / Questions
Imfinzi (durvalumab) - AstraZeneca
Tecentriq (atezolizumab) - Roche
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
Keytruda (pembrolizumab) - Merck (MSD)
http://www.ncbi.nlm.nih.gov/pubmed/42729427
Jinyi Tao; Zhiwen Fu
Sep 13, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next